Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors (Q46326788)
Jump to navigation
Jump to search
scientific article published on 16 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors |
scientific article published on 16 April 2013 |
Statements
1 reference
Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors (English)
1 reference
1 reference
Sunil Sharma
1 reference
Elisabeth G de Vries
1 reference
Jeffrey R Infante
1 reference
Corina N Oldenhuis
1 reference
Lin Yang
1 reference
Sanela Bilic
1 reference
Katie Parker
1 reference
Michael Goldbrunner
1 reference
Jeffrey W Scott
1 reference
Howard A Burris
1 reference
16 April 2013
1 reference
32
1 reference
1
1 reference
135-144
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference